Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 3/20 | 0.40 |
| ▸ | TTR | P02766 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | GSK3A | P49840 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.34 |
| ▸ | MEN1 | O00255 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL9841308 | 0.97 | CASP3 (0.39) | CASP3TTRCES1CA12CA1 | |
| SCHEMBL133474 | 0.85 | GSK3A (0.39) | CASP3TTRCES1CA12CA1 | |
| SCHEMBL2601688 | 0.76 | — | — | |
| SCHEMBL6366575 | 0.76 | F2 (0.48) | CASP3TTRCES1GSK3AGSK3B | |
| SCHEMBL24599365 | 0.73 | MEN1 (0.36) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6338046 | 0.73 | ADRA2C (0.32) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6614354 | 0.73 | ADRA2C (0.32) | CA12CA1CA2CA7CA9 | |
| SCHEMBL12220326 | 0.73 | ADRA2C (0.32) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10095225 | 0.71 | ADRA2C (0.30) | ADRA2CGSK3AGSK3BMGLLKMT2A | |
| SCHEMBL12588782 | 0.69 | ALDH1A1 (0.34) | KMT2AMEN1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070130702-A1 | Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative | L'OREAL S.A. | 2007-06-14 | — | — | US | claimed |
| US-7204857-B1 | Dyeing method using a specific active methylene compound and a compound selected among a specific aldehyde, a specific ketone, a quinone and a di-imino-isoindoline or 3-amino-isoindolone derivative | L'OREAL S.A. (FR) | 2007-04-17 | — | — | US | claimed |
| US-6635090-B1 | Dyeing method using a specific cationic derivative and a compound selected among a specific aldehyde, a specific ketone, a quinone and a di-imino-isoindoline or 3-amino-isoindolone derivative | L'OREAL, S.A. (FR) | 2003-10-21 | — | — | US | claimed |
| US-6458168-B1 | Hair dyeing method using an aliphatic cationic amine and compound chosen from an aldehyde, a ketone, a quinone, a di-imino-isoindoline, and a 3-aminoisoindolone derivative | L'OREAL S.A. (FR) | 2002-10-01 | — | — | US | claimed |
| US-20020131953-A1 | In situ langerhans cell vaccine | UT SOUTHWESTERN MEDICAL CENTER | 2002-09-19 | — | — | US | claimed |
| WO-2002072026-A2 | IN SITU LANGERHANS CELL VACCINE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-09-19 | — | — | WO | claimed |
| US-6451067-B1 | HAIR DYE MIXTURE | L'OREAL S.A. (FR) | 2002-09-17 | — | — | US | claimed |
| EP-0759040-B1 | CARBONYL CONTAINING COMPOUNDS AND THEIR DERIVATIVES AS MULTI-FUNCTIONAL FUEL AND LUBE ADDITIVES | EXXON RESEARCH ENGINEERING CO (US) | 1999-01-27 | — | — | EP | claimed |
| EP-0759040-A1 | CARBONYL CONTAINING COMPOUNDS AND THEIR DERIVATIVES AS MULTI-FUNCTIONAL FUEL AND LUBE ADDITIVES | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1997-02-26 | — | — | EP | claimed |
| WO-1995031488-A1 | CARBONYL CONTAINING COMPOUNDS AND THEIR DERIVATIVES AS MULTI-FUNCTIONAL FUEL AND LUBE ADDITIVES | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1995-11-23 | — | — | WO | claimed |
| EP-0208533-A2 | Shampoo compositions and use thereof | THE PROCTER & GAMBLE COMPANY (US) | 1987-01-14 | — | — | EP | claimed |
| US-20230137943-A1 | PHOTOPROXIMITY PROFILING OF PROTEIN-PROTEIN INTERACTIONS IN CELLS | THE UNIVERSITY OF CHICAGO | 2023-05-04 | — | — | US | disclosed |
| US-20230137943-A1 | PHOTOPROXIMITY PROFILING OF PROTEIN-PROTEIN INTERACTIONS IN CELLS | THE UNIVERSITY OF CHICAGO | 2023-05-04 | — | — | US | disclosed |
| EP-3180047-B1 | PROCESS FOR MANUFACTURING A CUSTOMIZABLE MEDICAL DEVICE AND DEVICE OBTAINED BY SAID PROCESS | INST DINVESTIGACIO BIOMEDICA DE BELLVITGE IDIBELL (ES) | 2018-10-24 | — | — | EP | disclosed |
| US-20170274123-A1 | PROCESS FOR MANUFACTURING A CUSTOMIZABLE MEDICAL DEVICE AND DEVICE OBTAINED BY SAID PROCESS | INSTITUT D'INVESTIGACIÓ BIOMÈDICA DE BELLVITGE (IDIBELL) (ES) | 2017-09-28 | — | — | US | disclosed |
| US-5288811-A | Cyclic carbonyl containing compounds via radical grafting | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1994-02-22 | — | — | US | disclosed |
| US-5254249-A | Anti-thrombogenic blood treating system | TORAY INDUSTRIES, INC. (JP) | 1993-10-19 | — | — | US | disclosed |
| EP-0412710-A2 | Vehicle systems for use in cosmetic compositions | THE PROCTER & GAMBLE COMPANY (US) | 1991-02-13 | — | — | EP | disclosed |
| EP-0404532-A1 | Antiperspirant compositions | THE PROCTER & GAMBLE COMPANY (US) | 1990-12-27 | — | — | EP | disclosed |
| EP-0133336-A1 | High strength, heat curable polyorganosiloxane elastomer compositions and method for preparing same | DOW CORNING CORPORATION (US) | 1985-02-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070130702-A1 | Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative | KRT18, NDUFB5, NDUFB7 | CASP3 1022/4885TTR 3199/4885CES1 3158/4885 |
| US-20230137943-A1 | PHOTOPROXIMITY PROFILING OF PROTEIN-PROTEIN INTERACTIONS IN CELLS | PPIA, S100A4, S100A6 | CASP3 2487/4885TTR 717/4885CES1 3820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.